201600930 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005018-17-NL (EUCTR)	14/05/2021	08/04/2021	Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS)	Targeting metabolic flexibility in ALS (MetFlex); Safety and tolerability of Trimetazidine for the t ...	Patients suffering from amyotrophic lateral sclerosis (ALS);Therapeutic area: Diseases [C] - Nervous ...	Trade Name: Vastarel Product Name: Trimetazidine Product Code: 201600930	The University of Queensland	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	36	Phase 2	Australia;Netherlands

First Previous1Next Last